← Back to catalogue
PathTezt Consumable - Slide
EUDAMEDClass A (EU MDR)
Ref CS-36100 Model 1. CS-36100 2. IS-36100 3. US-36100 4. HS-36100 5. CG-102450 6. GS-2500Ref GF-0825100Model 1. GF-0825100 2. NGF-0525100 3. UCF-0813100 4. PS-250 5. DF-2508
Identity
- Trade Name
- PathTezt Gyn Filter EUDAMED
- Device Name
- PathTezt Consumable - Slide EUDAMEDPathTezt Consumable - Filter EUDAMED
- Model / Reference
- 1. CS-36100 2. IS-36100 3. US-36100 4. HS-36100 5. CG-102450 6. GS-2500 EUDAMEDCS-36100 EUDAMED1. GF-0825100 2. NGF-0525100 3. UCF-0813100 4. PS-250 5. DF-2508 EUDAMEDGF-0825100 EUDAMED
Identifiers
- Primary DI / UDI-DI
- 09551020410504 EUDAMED
- Basic UDI-DI
- 955102041SlideQL EUDAMED955102041FilterXS EUDAMED
- EMDN Code
- W0503900201 MICROSCOPE SLIDES EUDAMEDW05030402 CELL AND TISSUE CULTURES, FILTERS EUDAMED
Classification
- Device Class
- Class A EUDAMED
- Market of Registration
- Austria EUDAMEDItaly EUDAMED
Clinical & Handling
Sterile
No
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
No
EUDAMED
Microbial Substances
No
EUDAMED
Reagent
No
EUDAMED
Self Testing
No
EUDAMED
Near-Patient Testing
No
EUDAMED
Professional Testing
No
EUDAMED
Companion Diagnostics
No
EUDAMED
Surgical Instrument
No
EUDAMED
New Device
No
EUDAMED
PathTezt Consumable - Slide by Biocytech Corporation Sdn Bhd — Class A — IVDR — listed in EUDAMED — regulatory data on deviCERTS
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/IVDR
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/IVDR | 955102041SlideQL | Class A | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Biocytech Corporation Sdn Bhd
- EUDAMED SRN
- MY-MF-000047354
- Authorised Representative
- SUNGO Europe B.V. NL-AR-000000247
Sources (2)
- EUDAMED 989a1829-15b7-4bbc-aef0-98d6ad4b64b0 61 fields · synced Jul 28, 2026
- EUDAMED 40df5b8d-039f-4645-a1b6-74a14f1f7f34 61 fields · synced Jul 28, 2026